OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted Protein Degradation: Advances, Challenges, and Prospects for Computational Methods
Barmak Mostofian, Holli‐Joi Martin, Asghar M. Razavi, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 17, pp. 5408-5432
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Simulation-based approaches for drug delivery systems: Navigating advancements, opportunities, and challenges
Iman Salahshoori, Mahdi Golriz, Marcos A.L. Nobre, et al.
Journal of Molecular Liquids (2023) Vol. 395, pp. 123888-123888
Open Access | Times Cited: 51

Targeting the undruggables—the power of protein degraders
Chao Zhang, Yongbo Liu, Guangchen Li, et al.
Science Bulletin (2024) Vol. 69, Iss. 11, pp. 1776-1797
Open Access | Times Cited: 18

Degraders in epigenetic therapy: PROTACs and beyond
Xing‐Jie Dai, Shi‐Kun Ji, Meng‐Jie Fu, et al.
Theranostics (2024) Vol. 14, Iss. 4, pp. 1464-1499
Open Access | Times Cited: 11

Efficient synthesis and molecular docking analysis of quinazoline and azole hybrid derivatives as promising agents for anti-cancer and anti-tuberculosis activities
Gourav Kumar, Parveen Kumar, Akta Soni, et al.
Journal of Molecular Structure (2024) Vol. 1310, pp. 138289-138289
Closed Access | Times Cited: 10

Innovative, combinatorial and high-throughput approaches to degrader synthesis
Rebecca Stevens, James D. F. Thompson, Julie C. L. Fournier, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 4838-4861
Closed Access | Times Cited: 9

Application of machine learning models for property prediction to targeted protein degraders
Giulia Peteani, Minh Huynh, Grégori Gerebtzoff, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7

Development of PROTACs using computational approaches
Jingxuan Ge, Chang-Yu Hsieh, Meijing Fang, et al.
Trends in Pharmacological Sciences (2024)
Closed Access | Times Cited: 6

PK/PD modeling of targeted protein degraders: Charting new waters and navigating the shallows
Robin Thomas Ulrich Haid, Andreas Reichel
Drug Discovery Today (2025), pp. 104311-104311
Open Access

A paradigm shift: analytical ultracentrifugation as a multi-attribute platform method in targeted protein degradation
Alexander E. Yarawsky, J.A. Ronau, Tiffany A. Thibaudeau, et al.
European Biophysics Journal (2025)
Closed Access

Computational approaches to aid PROTAC drug discovery
Sohini Chakraborti, Kirsten McAulay
Elsevier eBooks (2025)
Closed Access

Application of a bivalent “click” approach to target tyrosyl-DNA phosphodiesterase 1 (TDP1)
Xue Zhi Zhao, Wenjie Wang, Md Rasel Al Mahmud, et al.
RSC Medicinal Chemistry (2025)
Open Access

A Comprehensive Primer and Review of PROTACs and Their In Silico Design
Jacopo Zattoni, Paola Vottero, Gea Carena, et al.
Computer Methods and Programs in Biomedicine (2025) Vol. 264, pp. 108687-108687
Open Access

The Six Ds of Exponentials and drug discovery: A path toward reversing Eroom’s law
Alexander Tropsha, Holli‐Joi Martin, Artem Cherkasov
Drug Discovery Today (2025), pp. 104341-104341
Closed Access

Rational Proteolysis Targeting Chimera Design Driven by Molecular Modeling and Machine Learning
Shuoyan Tan, Zhuo Chen, Ruiqiang Lu, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2025) Vol. 15, Iss. 2
Closed Access

Modeling PROTAC degradation activity with machine learning
Stefano Ribes, Eva Nittinger, Christian Tyrchan, et al.
Artificial Intelligence in the Life Sciences (2024) Vol. 6, pp. 100104-100104
Open Access | Times Cited: 4

Next steps for targeted protein degradation
Mackenzie W. Krone, Craig M. Crews
Cell chemical biology (2024)
Closed Access | Times Cited: 3

To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives
Diana Castagna, Benoit Gourdet, Roland Hjerpe, et al.
Progress in medicinal chemistry (2024), pp. 61-160
Closed Access | Times Cited: 1

Structural Basis of Conformational Dynamics in the PROTAC-Induced Protein Degradation
Hongtao Zhao
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Non-Markovian Dynamic Models Identify Non-Canonical KRAS-VHL Encounter Complex Conformations for Novel PROTAC Design
Yunrui Qiu, Rafal Wiewiora, Jesús A. Izaguirre, et al.
JACS Au (2024) Vol. 4, Iss. 10, pp. 3857-3868
Open Access | Times Cited: 1

Corrigendum to “Modeling PROTAC degradation activity with machine learning” [Artif. Intell. Life Sci. 6 (2024) 100104]
Stefano Ribes, Eva Nittinger, Christian Tyrchan, et al.
Artificial Intelligence in the Life Sciences (2024) Vol. 6, pp. 100114-100114
Open Access

Efficient Sampling of PROTAC-Induced Ternary Complexes
Hongtao Zhao, Stefan Schießer, Christian Tyrchan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Computational strategies for the design of proteolysis targeting chimera degraders: Artificial intelligence enabled PROTAC design
Rajamanikkam Kamaraj, Radim Nencka, Petr Pávek
Annual reports in medicinal chemistry (2024)
Closed Access

Page 1 - Next Page

Scroll to top